Literature DB >> 10378569

Technetium Tc 99m sestamibi myocardial perfusion imaging: current role for evaluation of prognosis.

B P Mandalapu1, M Amato, H G Stratmann.   

Abstract

Like 201Tl imaging, technetium Tc 99m sestamibi (MIBI) myocardial imaging can be used with exercise and pharmacologic testing to assess the presence of coronary artery disease. An increasing body of literature indicates that MIBI can also be used to assess risk of future cardiac events such as myocardial infarction or death. This article summarizes the current status of MIBI imaging for evaluating prognosis in patients with known or suspected coronary artery disease.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10378569     DOI： 10.1378/chest.115.6.1684

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  10 in total

1.  Patient-centered imaging.

Authors:  E Gordon Depuey; John J Mahmarian; Todd D Miller; Andrew J Einstein; Christopher L Hansen; Thomas A Holly; Edward J Miller; Donna M Polk; L Samuel Wann
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

2.  Three-dimensional canine heart model for cardiac elastography.

Authors:  Hao Chen; Tomy Varghese
Journal:  Med Phys       Date:  2010-11       Impact factor: 4.071

3.  The prognostic value of myocardial perfusion scintigraphy: investigators, are you (mis)leading us?

Authors:  J J Borm; H Bouwsma; E E van der Wall; E K Pauwels
Journal:  Eur J Nucl Med       Date:  2001-09

4.  Myocardial perfusion defects and the left ventricular ejection fraction disclosed by scintigraphy in patients with primary hyperparathyroidism.

Authors:  Christina Gerlach Ogard; Susanne Bonnichsen Søndergaard; Henrik Vestergaard; Henrik Jakobsen; Steen Levin Nielsen
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

Review 5.  Imaging of Abdominal Aortic Aneurysm: the present and the future.

Authors:  Hao Hong; Yunan Yang; Bo Liu; Weibo Cai
Journal:  Curr Vasc Pharmacol       Date:  2010-11       Impact factor: 2.719

6.  Clinical significance of reverse redistribution on technetium-99m tetrofosmin single-photon emission computed tomography: an 18-month follow-up study.

Authors:  B M Swinkels; T E H Hooghoudt; E A J M Schoenmakers; C G Zinder; T M de Boo; F W A Verheugt
Journal:  Neth Heart J       Date:  2003-03       Impact factor: 2.380

7.  Long-term prognosis after a normal exercise stress Tc-99m sestamibi SPECT study.

Authors:  Abdou Elhendy; Arend Schinkel; Jeroen J Bax; Ron T van Domburg; Don Poldermans
Journal:  J Nucl Cardiol       Date:  2003 May-Jun       Impact factor: 5.952

8.  Could heart rate recovery and exercise capacity predict abnormal 99mTc-MIBI myocardial perfusion scan findings?

Authors:  Aryan Naghedi; Nasim Namiranian; Mohsen Goudarzi; Reza Nafisi Moghadam; Seid Kazem Razavi-Ratki
Journal:  Glob Cardiol Sci Pract       Date:  2021-04-30

9.  A modified regimen of extracorporeal cardiac shock wave therapy for treatment of coronary artery disease.

Authors:  Yu Wang; Tao Guo; Tie-Kun Ma; Hong-Yan Cai; Si-Ming Tao; Yun-Zhu Peng; Ping Yang; Ming-Qing Chen; Yun Gu
Journal:  Cardiovasc Ultrasound       Date:  2012-08-17       Impact factor: 2.062

10.  Pituitary incidentalomas detected with technetium-99m MIBI in patients with suspected parathyroid adenoma: preliminary results.

Authors:  Ekaterina Tiktinsky; Tifha Horne; Michael Friger; Svetlana Agranovich; Sophie Lantsberg
Journal:  World J Nucl Med       Date:  2012-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.